The effect of austenitization and intercritical annealing temperature on mechanical properties and work-hardening response of high-formability dual phase (DP) steel with low C and Mn content is studied. Different mechanisms of microstructural development are characterized. At intercritical temperature range, austenite forms in the ferritic matrix, which will transform to martensite during quenching. However, at austenitization temperatures, the material becomes completely austenitic with low hardenability. As a result, during quenching, there will be some ferrite phase in the martensitic matrix of the resultant DP steel. These differences are found to have important effects on the mechanical properties. The yield strength decreases at low martensite fraction due to the disappearance of the yield-point phenomenon and the presence of martensite-induced dislocations that move at low stresses. However, the yield strength rapidly increases by the dominance of the martensitic matrix at high martensite fractions. Moreover, the dependence of the ultimate tensile strength on martensite volume fraction is discussed based on the work-hardening capacity of the DP steels. Finally, the mechanical properties are summarized by consideration of strength-ductility trade-off seen for DP steels. Figure 8. The strength-ductility balance of DP steels [1] and its extension to high ductility region by including the results of the present study and results of Mirzadeh et al. [24] www.advancedsciencenews.com www.steel-research.de steel research int. 2018, 89, 1700412 www.advancedsciencenews.com www.steel-research.de steel research int. 2018, 89, 1700412
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.